CD4+ T cells from ME/CFS subjects had a greater change than controls’ cells in the oxygen consumption rate after injecting the fatty acid oxidation inhibitor etomoxir, indicating a greater contribution of this energy pathway compared to healthy control samples in a high-stress environment (Figure 5A). Here, CD4 is linked to myalgic encephalomeyelitis/chronic fatigue syndrome.